The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Moshurov R.I.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre, Moscow, Russia

Trifanov V.S.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre, Moscow, Russia

Grishin N.A.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre, Moscow, Russia

Volchenko N.N.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre, Moscow, Russia

Budurova M.D.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre, Moscow, Russia

Troitsky A.A.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre, Moscow, Russia

Poluektov S.I.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre, Moscow, Russia

Kosogolov M.V.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre, Moscow, Russia

Surgical treatment of neuroendocrine tumors of the pancreas of distal localisation

Authors:

Moshurov R.I., Trifanov V.S., Grishin N.A., Volchenko N.N., Budurova M.D., Troitsky A.A., Poluektov S.I., Kosogolov M.V.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2026;15(2): 12‑17

Read: 423 times


To cite this article:

Moshurov RI, Trifanov VS, Grishin NA, et al. Surgical treatment of neuroendocrine tumors of the pancreas of distal localisation. P.A. Herzen Journal of Oncology. 2026;15(2):12‑17. (In Russ.)
https://doi.org/10.17116/onkolog20261502112

Recommended articles:
Impact of cabe­rgoline on fibrosis in prolactinoma. Burdenko's Journal of Neurosurgery. 2026;(2):85-91

References:

  1. Liu C, Cheng H, Jin K. et al. Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma. Pancreas. 2018;47(6):742-747.  https://doi.org/10.1097/MPA.0000000000001073
  2. Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer. 2008;15(2):409-427.  https://doi.org/10.1677/ERC-07-0221
  3. Howe JR, Merchant NB, Conrad C, et al. The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors. Pancreas. 2020;49(1):1-33.  https://doi.org/10.1097/MPA.0000000000001454
  4. Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas. Neoplasia. 2017;19(12):991-1002. https://doi.org/10.1016/j.neo.2017.09.002
  5. Langhans T. Ueber einen Drüsenpolyp im Ileum. Virchows Arch. 1867; 38:559–560. 
  6. Ahmed M. Gastrointestinal neuroendocrine tumors in 2020. World J Gastrointest Oncol. 2020;12(8):791-807.  https://doi.org/10.4251/wjgo.v12.i8.791
  7. Ichikawa Y, Kobayashi N, Takano S, Kato I, Endo K, Inoue T. Neuroendocrine tumor theranostics. Cancer Sci. 2022;113(6):1930-1938. https://doi.org/10.1111/cas.15327
  8. Rindi G, Mete O, Uccella S. et al. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol. 2022;33(1):115-154.  https://doi.org/10.1007/s12022-022-09708-2
  9. Xu Z, Wang L, Dai S, et al. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States. JAMA Netw Open. 2021;4(9):e2124750. https://doi.org/10.1001/jamanetworkopen.2021.24750
  10. Ma ZY, Gong YF, Zhuang HK, et al. Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management. World J Gastroenterol. 2020;26(19):2305-2322. https://doi.org/10.3748/wjg.v26.i19.2305
  11. Guilmette JM, Nosé V. Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances. Adv Anat Pathol. 2019;26(1):13-30.  https://doi.org/10.1097/PAP.0000000000000201
  12. Scherübl H, Raue F, Frank-Raue K. Neuroendokrine Tumoren : Klassifikation, Klinik und Bildgebung [Neuroendocrine tumors : Classification, clinical presentation and imaging]. Radiologe. 2019;59(11):952-960.  https://doi.org/10.1007/s00117-019-0574-x
  13. Hallet J, Clarke CN. ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms. Ann Surg Oncol. 2024;31(3):1704-1713. https://doi.org/10.1245/s10434-023-14802-8
  14. Shyr BS, Shyr BU, Chen SC, Shyr YM, Wang SE. Impact of tumor grade on pancreatic neuroendocrine tumors. Asian J Surg. 2022;45(12):2659-2663. https://doi.org/10.1016/j.asjsur.2022.01.094
  15. Fani M, Mansi R, Nicolas GP, Wild D. Radiolabeled Somatostatin Analogs-A Continuously Evolving Class of Radiopharmaceuticals. Cancers (Basel). 2022;14(5):1172. https://doi.org/10.3390/cancers14051172
  16. Jiang L, Ning D, Chen XP. Improvement in distal pancreatectomy for tumors in the body and tail of the pancreas. World J Surg Oncol. 2021;19(1):49.  https://doi.org/10.1186/s12957-021-02159-9

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.